Affiliation:
1. Shumakov National Medical Research Center of Transplantology and Artificial Organs
2. Shumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov University
Abstract
Galectin-3 (Gal-3) is an important regulator of cell adhesion, migration, proliferation, differentiation and apoptosis under pathophysiological conditions. It plays a crucial role in diseases associated with chronic inflammation and fibrosis. In recent years, there have been reports indicating changes in serum Gal-3 levels in solid organ transplant recipients in the verification of kidney, liver, heart and lung transplant pathologies. Studies on Gal-3 levels and dynamics in solid organ recipients may serve to assess graft conditions using new minimally invasive methods and to identify therapeutic targets for personalized therapy. The first clinical trial data on Gal-3 pharmacological inhibition are emerging. This review summarizes the current understanding of the role of Gal-3 in transplant pathology and the prospects for its use as a diagnostic marker and therapeutic target in solid organ recipients.
Publisher
V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs
Subject
Transplantation,Immunology and Allergy
Reference65 articles.
1. Shevchenko AO. Metody ocenki i sravnitel’nogo analiza klinicheskoj jeffektivnosti biomarkerov pri diagnostike ostrogo koronarnogo sindroma. Biomarkery v laboratornoj diagnostike. Pod red. V.V. Dolgova, O.P. Shevchenko, A.O. Shevchenko. M.: Triada, 2014. 288 s.
2. Shevchenko OP, Aksyonova AV, Ulybysheva АА, Mozheiko NP, Nikitina EA, Orlov VI et al. Comparative analysis of diagnostic significance of biomarkers’ panels in cardiac recipients in the long term period after transplantation. Russian Journal of Transplantology and Artificial Organs. 2017; 19 (2): 27–33.
3. Park S, Nguyen NB, Pezhouman A, Ardehali R. Cardiac fibrosis: potential therapeutic targets. Transl Res. 2019 Jul; 209: 121–137. doi: 10.1016/j.trsl.2019.03.001.
4. Lahtin M, Lahtin V, Aleshkin V, Afanas’ev S. Lektiny poleznyh mikrobov: sistemnaja organizacija, funkcionirovanie i funkcional’noe supersemejstvo. Pol’za. Mikroby. 2011; 2: 155–165.
5. Slack RJ, Mills R, Mackinnon AC. The Therapeutic Potential of Galectin-3 Inhibition in Fibrotic Disease. Int J Biochem Cell Biol. 2021; 130: 105881.